• 11 July 2016

Switching from tenofovir DF to TAF improves bone and kidney safety

Read the article
  • 7 July 2016

HIV seroconversion is rare if Truvada PrEP is used consistently

Read the article
Slide from Gilead presentation at ASM Microbe 2016.
  • 6 July 2016

New integrase inhibitor bictegravir looks promising in early studies

Read the article
  • 5 July 2016

Atripla three times weekly maintains HIV viral suppression for 24 weeks

Read the article
  • 28 June 2016

PRO 140 antibody injections maintain viral suppression in phase 2 study

Read the article
Image from the CytoDyn PRO 140 video

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.